BANF1P1

Across TCGA pan-cancer cohorts, BANF1P1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of BANF1P1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where BANF1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types BANF1P1 is over-expressed in tumor, although a few such as BLCA and BRCA show the opposite, repressed pattern.

BLCA, KIRC, and BRCA are the cancer types where BANF1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BANF1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	−0.423	.012	6	view →
KIRC	All	III,IV	+0.100	.013	5	view →
BRCA	All	III,IV	−0.240	<.001	4	view →
THCA	All	All	−0.121	.006	3	view →
LIHC	Female	All	−0.182	.046	1	view →
KICH	All	All	−0.073	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

BANF1P1–BLCA

Open the BLCA breakdown →